{'52WeekChange': 1.731417,
 'SandP52WeekChange': None,
 'address1': '6340 Sequence Drive',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 425,
 'askSize': 1200,
 'averageDailyVolume10Day': 668650,
 'averageVolume': 1715714,
 'averageVolume10days': 668650,
 'beta': 0.780392,
 'beta3Year': None,
 'bid': 404.5,
 'bidSize': 1100,
 'bookValue': 10.125,
 'category': None,
 'circulatingSupply': None,
 'city': 'San Diego',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 424.8771,
 'dayLow': 402.72,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 157.867,
 'enterpriseToRevenue': 24.125,
 'enterpriseValue': 38614351872,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 405.75742,
 'fiftyTwoWeekHigh': 446.5,
 'fiftyTwoWeekLow': 138.28,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 91713239,
 'forwardEps': 3.01,
 'forwardPE': 140.11627,
 'fromCurrency': None,
 'fullTimeEmployees': 3900,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.00438,
 'heldPercentInstitutions': 1.00533,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': True,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/dexcom.com',
 'longBusinessSummary': 'DexCom, Inc., a medical device company, focuses on '
                        'the design, development, and commercialization of '
                        'continuous glucose monitoring (CGM) systems in the '
                        'United States and internationally. The company offers '
                        'its systems for use by people with diabetes, as well '
                        'as for use by healthcare providers. Its products '
                        'include DexCom G6, a CGM system for diabetes '
                        'management; DexCom G5 mobile CGM system to '
                        "communicate directly to patient's mobile device; "
                        'DexCom G4 PLATINUM system for continuous use by '
                        'adults with diabetes; and DexCom Share, a remote '
                        'monitoring system. DexCom, Inc. has a collaboration '
                        'and license agreement with Verily Life Sciences LLC '
                        'and Verily Ireland Limited to develop a series of '
                        'next-generation CGM products; and a collaboration '
                        'with Companion Medical, Inc. The company markets its '
                        'products directly to endocrinologists, physicians, '
                        'and diabetes educators. DexCom, Inc. was founded in '
                        '1999 and is headquartered in San Diego, California.',
 'longName': 'DexCom, Inc.',
 'market': 'us_market',
 'marketCap': 39770140672,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_114039',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 147900000,
 'nextFiscalYearEnd': 1640908800,
 'open': 420.46,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 3.53,
 'phone': '858 200 0200',
 'previousClose': 420.01,
 'priceHint': 2,
 'priceToBook': 41.65432,
 'priceToSalesTrailing12Months': 24.84702,
 'profitMargins': 0.0924,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 424.8771,
 'regularMarketDayLow': 402.72,
 'regularMarketOpen': 420.46,
 'regularMarketPreviousClose': 420.01,
 'regularMarketPrice': 420.46,
 'regularMarketVolume': 629199,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 94297904,
 'sharesPercentSharesOut': 0.0417,
 'sharesShort': 3933453,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 4772832,
 'shortName': 'DexCom, Inc.',
 'shortPercentOfFloat': 0.042,
 'shortRatio': 3.01,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'DXCM',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 1.591,
 'trailingPE': 265.08487,
 'twoHundredDayAverage': 320.00726,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '3ae7c86d-714e-392b-b6fd-23c89f3c2654',
 'volume': 629199,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.dexcom.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92121'}